EMEA Prostate Cancer Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2022

November 2017 | 119 pages | ID: E06A295F994EN
GlobalInfoResearch

Abstracts

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

SCOPE OF THE REPORT:

This report focuses on the Prostate Cancer Diagnostics in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Genomic Health
• Abbott
• OPKO
• Siemens Healthcare
• DiaSorin
• bioMeriux
• Roche
• MDx Health
• Beckman Coulter
• Myriad Genetics
• Ambry Genetics

Market Segment by Regions, regional analysis covers

• Europe (Germany, France, UK, Russia, Italy and Turkey)

Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)
Market Segment by Type, covers

• Tumor Biomarker Tests
• Imaging
• Biopsy
• Other

Market Segment by Applications, can be divided into

• < 55
• 55-75
• > 75

There are 13 Chapters to deeply display the EMEA Prostate Cancer Diagnostics market.

Chapter 1, to describe Prostate Cancer Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Prostate Cancer Diagnostics, with sales, revenue, and price of Prostate Cancer Diagnostics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Prostate Cancer Diagnostics, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Prostate Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Prostate Cancer Diagnostics research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Prostate Cancer Diagnostics Introduction
1.2 Market Analysis by Type
  1.2.1 Tumor Biomarker Tests
  1.2.2 Imaging
  1.2.3 Biopsy
  1.2.4 Other
1.3 Market Analysis by Applications
  1.3.1 <
  1.3.2 55-75
  1.3.3 >
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Genomic Health
  2.1.1 Business Overview
  2.1.2 Prostate Cancer Diagnostics Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
  2.2.1 Business Overview
  2.2.2 Prostate Cancer Diagnostics Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 OPKO
  2.3.1 Business Overview
  2.3.2 Prostate Cancer Diagnostics Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Siemens Healthcare
  2.4.1 Business Overview
  2.4.2 Prostate Cancer Diagnostics Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 DiaSorin
  2.5.1 Business Overview
  2.5.2 Prostate Cancer Diagnostics Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 bioMeriux
  2.6.1 Business Overview
  2.6.2 Prostate Cancer Diagnostics Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 bioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
  2.7.1 Business Overview
  2.7.2 Prostate Cancer Diagnostics Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 MDx Health
  2.8.1 Business Overview
  2.8.2 Prostate Cancer Diagnostics Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Beckman Coulter
  2.9.1 Business Overview
  2.9.2 Prostate Cancer Diagnostics Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Myriad Genetics
  2.10.1 Business Overview
  2.10.2 Prostate Cancer Diagnostics Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ambry Genetics
  2.11.1 Business Overview
  2.11.2 Prostate Cancer Diagnostics Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA PROSTATE CANCER DIAGNOSTICS MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA Prostate Cancer Diagnostics Sales and Market Share by Manufacturer
3.2 EMEA Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer
3.3 EMEA Prostate Cancer Diagnostics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share
  3.4.2 Top 5 Prostate Cancer Diagnostics Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY REGIONS

4.1 EMEA Prostate Cancer Diagnostics Sales, Revenue and Market Share by Regions
  4.1.1 EMEA Prostate Cancer Diagnostics Sales by Regions (2012-2017)
  4.1.2 EMEA Prostate Cancer Diagnostics Revenue by Regions (2012-2017)
4.2 Europe Prostate Cancer Diagnostics Sales and Growth (2012-2017)
4.3 Middle East Prostate Cancer Diagnostics Sales and Growth (2012-2017)
4.4 Africa Prostate Cancer Diagnostics Sales and Growth (2012-2017)

5 EUROPE PROSTATE CANCER DIAGNOSTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe Prostate Cancer Diagnostics Sales, Revenue and Market Share by Countries
  5.1.1 Europe Prostate Cancer Diagnostics Sales by Countries (2012-2017)
  5.1.2 Europe Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
  5.1.3 Germany Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  5.1.4 France Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  5.1.5 UK Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  5.1.6 Russia Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  5.1.7 Italy Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  5.1.8 Turkey Prostate Cancer Diagnostics Sales and Growth (2012-2017)
5.2 Europe Prostate Cancer Diagnostics Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe Prostate Cancer Diagnostics Sales by Manufacturers (2016-2017)
  5.2.2 Europe Prostate Cancer Diagnostics Revenue by Manufacturers (2016-2017)
5.3 Europe Prostate Cancer Diagnostics Sales by Type (2012-2017)
5.4 Europe Prostate Cancer Diagnostics Sales by Application (2012-2017)

6 MIDDLE EAST PROSTATE CANCER DIAGNOSTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East Prostate Cancer Diagnostics Sales, Revenue and Market Share by Countries
  6.1.1 Middle East Prostate Cancer Diagnostics Sales by Countries (2012-2017)
  6.1.2 Middle East Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  6.1.4 Israel Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  6.1.5 UAE Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  6.1.6 Iran Prostate Cancer Diagnostics Sales and Growth (2012-2017)
6.2 Middle East Prostate Cancer Diagnostics Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East Prostate Cancer Diagnostics Sales by Manufacturers (2016-2017)
  6.2.2 Middle East Prostate Cancer Diagnostics Revenue by Manufacturers (2016-2017)
6.3 Middle East Prostate Cancer Diagnostics Sales by Type (2012-2017)
6.4 Middle East Prostate Cancer Diagnostics Sales by Application (2012-2017)

7 AFRICA PROSTATE CANCER DIAGNOSTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa Prostate Cancer Diagnostics Sales, Revenue and Market Share by Countries
  7.1.1 Africa Prostate Cancer Diagnostics Sales by Countries (2012-2017)
  7.1.2 Africa Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
  7.1.3 South Africa Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  7.1.4 Nigeria Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  7.1.5 Egypt Prostate Cancer Diagnostics Sales and Growth (2012-2017)
  7.1.6 Algeria Prostate Cancer Diagnostics Sales and Growth (2012-2017)
7.2 Middle East Prostate Cancer Diagnostics Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East Prostate Cancer Diagnostics Sales by Manufacturers (2016-2017)
  7.2.2 Middle East Prostate Cancer Diagnostics Revenue by Manufacturers (2016-2017)
7.3 Middle East Prostate Cancer Diagnostics Sales by Type (2012-2017)
7.4 Middle East Prostate Cancer Diagnostics Sales by Application (2012-2017)

8 EMEA PROSTATE CANCER DIAGNOSTICS MARKET SEGMENT BY TYPE

8.1 EMEA Prostate Cancer Diagnostics Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA Prostate Cancer Diagnostics Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA Prostate Cancer Diagnostics Revenue and Market Share by Type (2012-2017)
8.2 Tumor Biomarker Tests Sales Growth and Price
  10.2.1 EMEA Tumor Biomarker Tests Sales Growth (2012-2017)
  10.2.2 EMEA Tumor Biomarker Tests Price (2012-2017)
8.3 Imaging Sales Growth and Price
  10.3.1 EMEA Imaging Sales Growth (2012-2017)
  10.3.2 EMEA Imaging Price (2012-2017)
8.4 Biopsy Sales Growth and Price
  10.4.1 EMEA Biopsy Sales Growth (2012-2017)
  10.4.2 EMEA Biopsy Price (2012-2017)
8.5 Other Sales Growth and Price
  10.5.1 EMEA Other Sales Growth (2012-2017)
  10.5.2 EMEA Other Price (2012-2017)

9 EMEA PROSTATE CANCER DIAGNOSTICS MARKET SEGMENT BY APPLICATION

9.1 EMEA Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
9.2 < 55 Sales Growth (2012-2017)
9.3 55-75 Sales Growth (2012-2017)
9.4 > 75 Sales Growth (2012-2017)

10 EMEA PROSTATE CANCER DIAGNOSTICS MARKET FORECAST (2017-2022)

10.1 EMEA Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2017-2022)
10.2 Prostate Cancer Diagnostics Market Forecast by Regions (2017-2022)
  10.2.1 Europe Prostate Cancer Diagnostics Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.1.2 France Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.1.3 UK Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.1.4 Russia Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.1.5 Italy Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.1.6 Turkey Prostate Cancer Diagnostics Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.2.2 Israel Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.2.3 UAE Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.2.4 Iran Prostate Cancer Diagnostics Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.3.2 Nigeria Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.3.3 Egypt Prostate Cancer Diagnostics Sales Forecast 2017-2022
    10.2.3.4 Algeria Prostate Cancer Diagnostics Sales Forecast 2017-2022
10.3 Prostate Cancer Diagnostics Market Forecast by Type (2017-2022)
10.4 Prostate Cancer Diagnostics Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Prostate Cancer Diagnostics Picture
Table Product Specifications of Prostate Cancer Diagnostics
Figure EMEA Sales Market Share of Prostate Cancer Diagnostics by Types in 2016
Table Prostate Cancer Diagnostics Types for Major Manufacturers
Figure Tumor Biomarker Tests Picture
Figure Imaging Picture
Figure Biopsy Picture
Figure Other Picture
Table Prostate Cancer Diagnostics Sales Market Share by Applications in 2016
Figure < 55 Picture
Figure 55-75 Picture
Figure > 75 Picture
Figure Germany Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure France Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure UK Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Prostate Cancer Diagnostics Revenue (Value) and Growth Rate (2012-2022)
Table Genomic Health Basic Information, Manufacturing Base and Competitors
Table Genomic Health Prostate Cancer Diagnostics Type and Applications
Table Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Prostate Cancer Diagnostics Type and Applications
Table Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OPKO Basic Information, Manufacturing Base and Competitors
Table OPKO Prostate Cancer Diagnostics Type and Applications
Table OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Prostate Cancer Diagnostics Type and Applications
Table Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table DiaSorin Basic Information, Manufacturing Base and Competitors
Table DiaSorin Prostate Cancer Diagnostics Type and Applications
Table DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table bioMeriux Basic Information, Manufacturing Base and Competitors
Table bioMeriux Prostate Cancer Diagnostics Type and Applications
Table bioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Prostate Cancer Diagnostics Type and Applications
Table Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MDx Health Basic Information, Manufacturing Base and Competitors
Table MDx Health Prostate Cancer Diagnostics Type and Applications
Table MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table Beckman Coulter Prostate Cancer Diagnostics Type and Applications
Table Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table Myriad Genetics Prostate Cancer Diagnostics Type and Applications
Table Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ambry Genetics Basic Information, Manufacturing Base and Competitors
Table Ambry Genetics Prostate Cancer Diagnostics Type and Applications
Table Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Prostate Cancer Diagnostics Sales by Manufacturer (2016-2017)
Figure EMEA Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2016
Figure EMEA Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2017
Table EMEA Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
Figure EMEA Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2016
Figure EMEA Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2017
Table EMEA Prostate Cancer Diagnostics Price by Manufacturer (2016-2017)
Figure EMEA Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure EMEA Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales by Regions (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales Market Share by Regions (2012-2017)
Figure EMEA Prostate Cancer Diagnostics Sales Market Share by Regions in 2012
Figure EMEA Prostate Cancer Diagnostics Sales Market Share by Regions in 2016
Table EMEA Prostate Cancer Diagnostics Revenue by Regions (2012-2017)
Table EMEA Prostate Cancer Diagnostics Revenue Market Share by Regions (2012-2017)
Figure EMEA Prostate Cancer Diagnostics Revenue Market Share by Regions in 2012
Figure EMEA Prostate Cancer Diagnostics Revenue Market Share by Regions in 2016
Figure Europe Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Africa Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Europe Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Table Europe Prostate Cancer Diagnostics Sales by Countries (2012-2017)
Table Europe Prostate Cancer Diagnostics Sales Market Share by Countries (2012-2017)
Figure Europe Prostate Cancer Diagnostics Sales Market Share by Countries in 2012
Figure Europe Prostate Cancer Diagnostics Sales Market Share by Countries in 2016
Table Europe Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
Table Europe Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Europe Prostate Cancer Diagnostics Revenue Market Share by Countries in 2012
Figure Europe Prostate Cancer Diagnostics Revenue Market Share by Countries in 2016
Figure Germany Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure France Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure UK Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Russia Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Italy Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Turkey Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table Europe Prostate Cancer Diagnostics Sales by Manufacturer (2016-2017)
Figure Europe Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2016
Figure Europe Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2017
Table Europe Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
Figure Europe Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2016
Figure Europe Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2017
Table Europe Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table Europe Prostate Cancer Diagnostics Sales Share by Type (2012-2017)
Table Europe Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table Europe Prostate Cancer Diagnostics Sales Share by Application (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales by Countries (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales Market Share by Countries (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Sales Market Share by Countries in 2012
Figure Middle East Prostate Cancer Diagnostics Sales Market Share by Countries in 2016
Table Middle East Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
Table Middle East Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Revenue Market Share by Countries in 2012
Figure Middle East Prostate Cancer Diagnostics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Israel Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure UAE Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Iran Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales by Manufacturer (2016-2017)
Figure Middle East Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2016
Figure Middle East Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2017
Table Middle East Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
Figure Middle East Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2016
Figure Middle East Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2017
Table Middle East Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales Share by Type (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales Share by Application (2012-2017)
Figure Africa Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Table Africa Prostate Cancer Diagnostics Sales by Countries (2012-2017)
Table Africa Prostate Cancer Diagnostics Sales Market Share by Countries (2012-2017)
Figure Africa Prostate Cancer Diagnostics Sales Market Share by Countries in 2012
Figure Africa Prostate Cancer Diagnostics Sales Market Share by Countries in 2016
Table Africa Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
Table Africa Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Africa Prostate Cancer Diagnostics Revenue Market Share by Countries in 2012
Figure Africa Prostate Cancer Diagnostics Revenue Market Share by Countries in 2016
Figure South Africa Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Nigeria Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Egypt Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Figure Algeria Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales by Manufacturer (2016-2017)
Figure Middle East Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2016
Figure Middle East Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2017
Table Middle East Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
Figure Middle East Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2016
Figure Middle East Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2017
Table Middle East Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales Share by Type (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales Share by Application (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales Share by Type (2012-2017)
Table EMEA Prostate Cancer Diagnostics Revenue by Type (2012-2017)
Table EMEA Prostate Cancer Diagnostics Revenue Share by Type (2012-2017)
Figure EMEA Tumor Biomarker Tests Sales Growth (2012-2017)
Figure EMEA Tumor Biomarker Tests Price (2012-2017)
Figure EMEA Imaging Sales Growth (2012-2017)
Figure EMEA Imaging Price (2012-2017)
Figure EMEA Biopsy Sales Growth (2012-2017)
Figure EMEA Biopsy Price (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Other Price (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales Share by Application (2012-2017)
Figure EMEA < 55 Sales Growth (2012-2017)
Figure EMEA 55-75 Sales Growth (2012-2017)
Figure EMEA > 75 Sales Growth (2012-2017)
Figure EMEA Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Prostate Cancer Diagnostics Sales Forecast by Regions (2017-2022)
Table EMEA Prostate Cancer Diagnostics Market Share Forecast by Regions (2017-2022)
Table Europe Prostate Cancer Diagnostics Sales Forecast by Regions (2017-2022)
Figure Germany Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure France Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure UK Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure Russia Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure Italy Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure Turkey Prostate Cancer Diagnostics Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure Israel Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure UAE Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure Iran Prostate Cancer Diagnostics Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure Nigeria Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure Egypt Prostate Cancer Diagnostics Sales Forecast 2017-2022
Figure Algeria Prostate Cancer Diagnostics Sales Forecast 2017-2022
Table EMEA Prostate Cancer Diagnostics Sales Forecast by Type (2017-2022)
Table EMEA Prostate Cancer Diagnostics Market Share Forecast by Type (2017-2022)
Table EMEA Prostate Cancer Diagnostics Sales Forecast by Application (2017-2022)
Table EMEA Prostate Cancer Diagnostics Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List